Analyst Ratings for Biohaven Pharmaceutical Holding (BHVN)

BHVN Rating Summary

BHVN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BHVN
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $153.30 (+6.6%) * Over Last 12-Mos
Rating Score: 5.7 / 10   Percentile Rank: 57%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/11/2022 H.C. Wainwright Douglas Tsao Downgrade Neutral
(Buy)
N/A
(N/A)
140.00
(143.79)
2.71% Details
5/11/2022 SVB Leerink Marc Goodman Downgrade Market Perform
(Outperform)
150.00
(N/A)
83.14
(143.79)
72.95% Details
Like BHVN Ratings? Also take a look at PRTG, PFE, BMY, BIIB

BHVN Ratings News